Fresenius Medical Care Corporation

$ 22.03

0.46%

05 Jun - close price

  • Market Cap 11,832,958,000 USD
  • Current Price $ 22.03
  • High / Low $ 22.11 / 21.93
  • Stock P/E 11.59
  • Book Value 28.55
  • EPS 1.90
  • Next Earning Report 2026-08-04
  • Dividend Per Share $1.49
  • Dividend Yield 3.96 %
  • Next Dividend Date 2026-06-08
  • ROA 0.04 %
  • ROE 0.08 %
  • 52 Week High 27.94
  • 52 Week Low 19.24

About

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Analyst Target Price

$26.47

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-05-052026-02-242025-11-042025-08-052025-05-062025-02-252024-11-052024-07-302024-05-072024-02-202023-11-012023-08-02
Reported EPS 0.4550.720.550.460.420.4550.410.350.320.440.280.3
Estimated EPS 0.52650.550.50.470.380.40050.350.340.250.30.310.28
Surprise -0.07150.170.05-0.010.040.05450.060.010.070.14-0.030.02
Surprise Percentage -13.5802%30.9091%10%-2.1277%10.5263%13.608%17.1429%2.9412%28%46.6667%-9.6774%7.1429%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-08-04
Fiscal Date Ending 2026-06-30
Estimated EPS 0.49
Currency EUR

Previous Dividend Records

Jun 2026Jun 2025Jun 2024Jun 2023May 2022Jan 1970Sep 2020Jan 1970Jan 1970Jan 1970
Payment Date 2026-06-082025-06-062024-06-032023-06-012022-05-27None2020-09-11NoneNoneNone
Amount $0.871575$0.787104$0.634151$0.618126$0.70929$0.833748$0.71688$0.655083$0.632343$0.370436

Next Dividend Records

Dividend per share (year): $1.49
Dividend Yield 3.96%
Next Dividend Date 2026-06-08
Ex-Dividend Date 2026-05-22

Recent News: FMS

...
FMS Launches kinexus Digital Platform for Home Dialysis Care

2026-06-05 15:38:44

Fresenius Medical Care AG & Co. (FMS) has launched kinexus, a new digital platform designed to enhance home dialysis programs. This platform integrates remote monitoring, prescription management, and operational workflows for both peritoneal dialysis (PD) and home hemodialysis (HHD). The launch aims to strengthen home dialysis through digital infrastructure, capitalize on the growing home dialysis market, and streamline patient care by consolidating various management aspects into a single system.

Fresenius Medical Care AG commences an Equity Buyback Plan for 279,288,885 shares, representing 10% of its issued share capital, under the authorization approved on May 21, 2026.

2026-05-28 12:10:31

Fresenius Medical Care AG has started an equity buyback plan for up to 279,288,885 shares, representing 10% of its issued share capital. This program was authorized by shareholders on May 21, 2026, and allows for repurchases on the stock exchange or through public offers, with specific price limitations. The repurchased shares can be redeemed, sold to third parties for cash or assets, or used for employee incentive plans and to service convertible bonds.

...
Fresenius SE & Co. KGaA stock (DE0005785604): Healthcare group realigns portfolio after Fresenius Me

2026-05-27 22:10:04

Fresenius SE & Co. KGaA is undergoing a significant portfolio realignment, deconsolidating Fresenius Medical Care to concentrate on hospitals, pharmaceuticals, and healthcare services. The company's core segments, Helios, Kabi, and Vamed, aim to capitalize on structural healthcare demand while navigating regulatory and cost pressures. This strategic shift involves efficiency programs and a focused capital allocation to enhance profitability and cash generation for the internationally oriented healthcare provider.

...
UBS Group AG Reduces Holdings in Fresenius Medical Care AG & Co. KGaA $FMS

2026-05-27 11:09:17

UBS Group AG significantly reduced its stake in Fresenius Medical Care AG & Co. KGaA by 33.6% in the fourth quarter, selling over 51,000 shares. Despite this, other institutional investors increased their holdings, while analyst sentiment remains cautious with an average "Reduce" rating and a $28.00 target price. The company recently increased its annual dividend to $0.8716 per share, following quarterly earnings of $1.05 EPS on $5.34 billion in revenue.

...
A Look at Fresenius Medical Care AG (FMS) After 3.8% Decline -- GF Value $24.03 vs Price $21.64

2026-05-22 17:06:09

Fresenius Medical Care AG (FMS) shares dropped 3.8% to $21.64, closing below its GF Valueâ„¢ estimate of $24.03, indicating it is "Modestly Undervalued." The company holds a GF Scoreâ„¢ of 73/100, highlighting strong valuation but concerns in growth and momentum. Despite its undervaluation and low P/E ratio compared to historical averages, investors are cautioned due to its 1-star predictability rating and absence of insider transactions over the last three months.

...
Pzena Investment Management LLC Sells 64,016 Shares of Fresenius Medical Care AG & Co. KGaA $FMS

2026-05-22 11:09:14

Pzena Investment Management LLC reduced its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 0.4% in the fourth quarter, selling 64,016 shares, but still holds significant shares worth $351.4 million. Despite increased positions from several institutional investors, overall institutional ownership remains low at 8.37%. Analyst consensus is a "Reduce" rating with a $28.00 price target, while the company recently increased its annual dividend to $0.8716 per share.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi